Thailand - Delayed Quote THB

Bumrungrad Hospital Public Company Limited (BH.BK)

166.00
-3.00
(-1.78%)
At close: April 24 at 4:39:13 PM GMT+7
Currency in THB All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,717,577.32
25,717,577.32
25,376,158.56
20,720,563.66
12,460,420.94
Cost of Revenue
12,503,044.11
12,503,044.11
12,894,825.87
11,099,259.81
7,730,980.53
Gross Profit
13,214,533.21
13,214,533.21
12,481,332.69
9,621,303.85
4,729,440.41
Operating Expense
4,026,463.29
4,026,463.29
4,009,390.67
3,610,975.20
3,151,810.29
Operating Income
9,188,069.92
9,188,069.92
8,471,942.02
6,010,328.65
1,577,630.12
Net Non Operating Interest Income Expense
271,138.42
271,138.42
138,554.89
42,407.48
-50,971.42
Other Income Expense
-23,161.28
-23,161.28
27,158.34
-3,780.64
-70,779.03
Pretax Income
9,436,047.06
9,436,047.06
8,637,655.25
6,048,955.49
1,455,879.68
Tax Provision
1,603,990.08
1,603,990.08
1,582,523.60
1,072,193.32
215,846.91
Net Income Common Stockholders
7,774,725.88
7,774,725.88
7,006,450.98
4,938,221.85
1,215,678.23
Diluted NI Available to Com Stockholders
7,774,725.88
7,774,725.88
7,006,450.98
4,938,221.85
1,215,678.23
Basic EPS
9.78
9.78
8.81
6.21
1.53
Diluted EPS
8.96
8.96
8.08
5.69
1.40
Basic Average Shares
794,911
794,911
794,886
794,838
794,586
Diluted Average Shares
867,415
867,415
867,415
867,415
867,415
Total Operating Income as Reported
9,165,335.92
9,165,335.92
8,499,997.65
6,007,057.98
1,519,269.04
Rent Expense Supplemental
85,719
85,719
71,031
46,112
--
Total Expenses
16,529,507.40
16,529,507.40
16,904,216.54
14,710,235
10,882,790.82
Net Income from Continuing & Discontinued Operation
7,774,725.88
7,774,725.88
7,006,450.98
4,938,221.85
1,215,678.23
Normalized Income
7,793,595.43
7,793,595.43
6,983,535.49
4,940,912.79
1,265,386.77
Interest Income
279,473.23
279,473.23
140,948.46
45,954.27
68,784.48
Interest Expense
8,334.81
8,334.81
2,393.57
3,546.79
119,755.90
Net Interest Income
271,138.42
271,138.42
138,554.89
42,407.48
-50,971.42
EBIT
9,444,381.87
9,444,381.87
8,640,048.82
6,052,502.28
1,575,635.58
EBITDA
10,521,617.87
10,521,617.87
9,736,816.82
7,169,377.28
2,755,557.21
Reconciled Cost of Revenue
12,503,044.11
12,503,044.11
12,894,825.87
11,099,259.81
7,730,980.53
Reconciled Depreciation
1,077,236
1,077,236
1,096,768
1,116,875
1,179,921.64
Net Income from Continuing Operation Net Minority Interest
7,774,725.88
7,774,725.88
7,006,450.98
4,938,221.85
1,215,678.23
Total Unusual Items Excluding Goodwill
-22,734
-22,734
28,055.62
-3,270.68
-58,361.08
Total Unusual Items
-22,734
-22,734
28,055.62
-3,270.68
-58,361.08
Normalized EBITDA
10,544,351.87
10,544,351.87
9,708,761.20
7,172,647.96
2,813,918.29
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,864.45
-3,864.45
5,140.13
-579.74
-8,652.54
12/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers